1-D
1-D WESTERN BLOT ANALYSIS
1-D WESTERN BLOT ANALYSIS
2-D
2-D
2-D WESTERN BLOT ARRAY METHODOLOGY
2-D WESTERN MULTIPROTEIN ARRAY
2-D GEL
AP-1
ACTIVATED NF-ΚB TRANSLOCATION
AEBERSOLE
APOPTOSI
APOPTOSI
APOPTOSIS ASSAY
APOPTOTIC CELL APOPTOSIS ASSAY
APOPTOTIC CELL
APOPTOTIC NUCLEUS
APOSTAIN
APOSTAIN
ATLAS
PURE TOTAL RNA ATLAS
BD SIGNAL TRANSDUCTION
2-D BD SIGNAL TRANSDUCTION
BGJB
BGJB MEDIUM
BMP1
BMP1
BIOMOL RESEARCH
C-19
C-20
CYPROTERONE ACETATE
CYPROTERONE ACETATE
CYPROTERONE ACETATE
CYPROTERONE ACETATE
CONT
CONT
CONT
CONT
CONT
CONT
CONT
CONT
CONT
CONT
CONT
CONT PROTEIN
CORT
CORT
CORT/GR
CORT/GR FUNCTION
CANALICULAR
CANALICULAR STAGE
CANALICULAR STAGE
CASPASE
CASPASE
CASPASE
CASPASE
CASPASE
CASPASE
CASPASE
CASPASE
CASPASE
CASPASE
CASPASE
CASPASE
CASPASE
CASPASE
CASPASE
CASPASE
CASPAS
CHK1
CHK2
CLONTECH
CLONTECH ATLAS IMAGE
COMPLEX NETWORK
BIOLOGICAL SIGNALING PATHWAY COMPLEX NETWORK
CONNECTION MAP
CONNECTIONS MAP
CONNECTIONS MAP
CONNECTIONS MAP
CONNECTIONS MAP
CONNECTIONS MAP
CONNECTIONS MAP
CONTEMPORANEOUS PROTEOME ANALYSIS
CULTURE SYSTEM E15 SMG
CULTURED EXPLANT MORPHOGENESI
CYCLIN D2
D214
DEPC
DNA
DNA
DNA ELEMENT
DNA FRAGMENTATION
DNA REPAIR
DNA RESPONSE ELEMENT
DNA STABILITY
E11
E14
E15
E15
E15
E15
E15
E15
E15
E15
E15
E15
E15
E15
E15 SMG PRIMORDIA
E15 SMG PRIMORDIA
E15 SMG
E15 CONTROL
E15 PRIMORDIA
E15-18
E17 SMG HOMOGENATE
E17 SMG
E18
EGF
EXTRACELLULAR SIGNAL REGULATED KINASE
EXTRACELLULAR SIGNAL REGULATED KINASE
ERK1
ERK1
ERK1
ERK1
ERK2
ERK2
EPITHELIAL CELL APOPTOSI
EPITHELIAL CELL PROLIFERATION
EXPLANT
EXPRESSHYB SOLUTION
FAF
FAF
FAF
FAF
FGF
SIGNALING PATHWAY FGF
FL
FAS RECEPTOR
FAS/CASPASE
FUNCTIONAL GENOMIC ANALYSIS
GLUCOCORTICOID RECEPTOR
GLUCOCORTICOID RECEPTOR
GLUCOCORTICOID RECEPTOR
GLUCOCORTICOID RECEPTOR
GLUCOCORTICOID RECEPTOR
GR ASSOCIATE
GR PROTEIN EXPRESSION
GR PROTEIN EXPRESSION
GR PROTEIN LEVEL
GLUCOCORTICOID HORMONE RESPONSIVE ELEMENTS
GENE/PROTEIN DIFFERENCE
GLUCOCORTICOID
HRP-LABELED
HISTOLOGY
HYBRIDIZATION SIGNAL
IGF
IGF2
IGFBP3
IL-1
INTERLEUKIN 2
IL-6
IL-6
IL-6R
IL-8
INCREASING CORT/GR FUNCTION
IΚB PROTEIN
JAK
JAK/STAT
JAK1
JUN N TERMINAL           KINASE
JUN N TERMINAL           KINASE
JUNKRAT CELL
JURKAT CELL
KY
LABELING SYSTEM
LEXINGTON
MAP KINASE
MAPK/ERK
MAPK/ERK CASCADE
MAPK/ERK PATHWAY
MN
MAB
MAB F7-26
MAB F7-26
MAB F7-26
MAB STAINING
APOPTOTIC CELL MAB STAINING
MAP PROTEIN
MAP PROTEIN
MAP TRANSCRIPT
MAP TRANSCRIPT
MAP TRANSCRIPTS EXHIBIT
ALTERED EXPRESSION MAP TRANSCRIPTS EXHIBIT
MEAN RATIO
MEAN RATIO
MIAMI
MINNEAPOLI
NF-ΚB
NF-ΚB
NF-ΚB
NF-ΚB
NF-ΚB
NF-ΚB
NF-ΚB
NF-ΚB
NF-ΚB
NF-ΚB
NF-ΚB
NF-ΚB
NF-ΚB
NF-ΚB
NF-ΚB
NF-ΚB
NF-ΚB
NF-ΚB
NF-ΚB
NF-ΚB
NF-ΚB ACTIVATION
NF-ΚB ACTIVATION
NF-ΚB ACTIVATION
NF-ΚB BOUND
NF-ΚB BOUND
NF-ΚB INHIBITION
NF-ΚB INHIBITION
NF-ΚB INHIBITION
NF-ΚB INHIBITION
NF-ΚB INHIBITION
NF-ΚB P50
NF-ΚB P50
NF-ΚB P50
NF-ΚB P50
NF-ΚB P50
NF-ΚB P52
NF-ΚB P65
NF-ΚB REDISTRIBUTION
NF-ΚB RESPONSE GENE
NF-ΚB SIGNAL
NF-ΚB SIGNALING
NF-ΚB SIGNALING
NF-ΚB TRANSCRIPTION FACTOR
NF-ΚB TRANSLOCATION
NF-ΚB TRANSLOCATION
NF-ΚB TRANSLOCATION
NF-ΚB TRANSLOCATION
NF-ΚB TRANSLOCATION
NF-ΚB-DEPENDENT INHIBITION
SMAD7 NF-ΚB-DEPENDENT INHIBITION
NF-ΚB-INHIBITED EXPLANT
NF-ΚB-INHIBITED PHENOTYPE
NF-ΚB-MEDIATED TRANSCRIPTION
NF-ΚB-MEDIATED TRANSCRIPTION
NFAT
NUCLEAR LOCALIZATION           SEQUENCE
NUCLEAR LOCALIZATION           SEQUENCE
NUCLEAR LOCALIZATION           SEQUENCE
NF-ΚB P50 NUCLEAR LOCALIZATION           SEQUENCE
RECEPTOR COMPLEX NUCLEAR LOCALIZATION           SEQUENCE
NEGATIVE CONTROL
PARP
PARP
PARP
PARP CLEAVAGE
PHOSPHATE BUFFERED SALINE
PHOSPHATE BUFFERED SALINE
PHOSPHATE BUFFERED SALINE
CONTAINING LYSINE-RICH HISTONE PHOSPHATE BUFFERED SALINE
PCNA
PCNA
PCNA
PCNA PROTEIN
PCNA TRANSCRIPT
PCNA TRANSCRIPT
PCNA-DEFINED CELL PROLIFERATION
PCNA-DEFINED CELL PROLIFERATION
PCNA-POSITIVE CELL
PCNA-POSITIVE EPITHELIAL CELLS/TOTAL EPITHELIAL CELL
PNN ANALYSIS
PNN ANALYSIS
PNN ANALYSIS
PNN ANALYSIS
PNN ANALYSIS
PNN ANALYSIS
PNN ANALYSIS
PNN ANALYSIS SHOW
PNN ANALYSIS SHOW
PNN ANALYSIS SHOW
PALO ALTO
PLYMOUTH MEETING
POSITIVE CONTROL
POWERBLOT WESTERN ARRAY
PROBABILISTIC NEURAL NETWORK
PROBABILISTIC NEURAL NETWORK ANALYSIS
PROGRESSIVE PRENATAL MORPHOGENESI
PSEUDOGLANDULAR
PURE TOTAL RNA
QUANTITATION
QUANTITATION
QUANTITATION
APOPTOTIC NUCLEUS QUANTITATION
RADIOIMMUNOASSAY
RAF
RAS/RAF
RAS/RAF
RAS/RAF
RAS/RAF/ERK
RELA
RELA ANTIBODY
RELB P68
RELEASED NF-ΚB DIMER
RELEVANT GENE
ROCKVILLE
S1 NUCLEASE
S1 NUCLEASE
SHP-2
SUBMANDIBULAR         SALIVARY GLAND
SUBMANDIBULAR         SALIVARY GLAND
SUBMANDIBULAR         SALIVARY GLAND
SUBMANDIBULAR         SALIVARY GLAND
SUBMANDIBULAR         SALIVARY GLAND
SMG CORT
SMG CORT
SMG GR
SMG GR
SMG GR
BRANCHING MORPHOGENESI SUBMANDIBULAR         SALIVARY GLAND
SMG CELLULAR
SMG DEVELOPMENT
SMG DEVELOPMENT
SMG DEVELOPMENT
SMG DYSPLASIA
SMG EPITHELIA NUCLEUS
SMG EPITHELIAL CELL PROLIFERATION
SMG EXPLANTS RESULT
SMG HARVESTING
SMG MORPHOGENESI
SMG MORPHOGENESI
SMG PHENOTYPE
SMG PHENOTYPE
SMG PHENOTYPE
SMG
SMGS DEPRIVED
NF-ΚB SMGS DEPRIVED
SN50
SN50
SN50
SN50
SN50
SN50
SN50
SN50
SN50 SMG
SN50 PEPTIDE
SN50 PHENOTYPE
SN50 PHENOTYPE
SN50 PHENOTYPE
SN50 RESULT
SN50 TREATMENT
SN50 TREATMENT
SN50 TREATMENT
INHIBITED NB-ΚB ACTIVATION SN50 TREATMENT
SN50-AND MSN50 PEPTIDE-TREATED EXPLANT
SN50-INDUCED NF-ΚB INHIBITION
SN50-MEDIATED INHIBITION
SN50-MEDIATED INHIBITION
NF-ΚB SN50-MEDIATED INHIBITION
NF-ΚB SN50-MEDIATED INHIBITION
SN50-SUPPLEMENTED MEDIUM
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED E15
SN50-TREATED E15
SN50-TREATED E15
SN50-TREATED E15
SN50-TREATED E15
SN50-TREATED SMG
SN50-TREATED SMG
SN50-TREATED SMG
SN50-TREATED SMG
SN50-TREATED EXPLANT
SN50-TREATED EXPLANT
SN50-TREATED EXPLANT
SN50-TREATED EXPLANT
SN50-TREATED EXPLANT
SN50-TREATED EXPLANT
SN50-TREATED EXPLANT
SN50-TREATED EXPLANT
SN50-TREATED EXPLANT
SN50-TREATED EXPLANT
SN50-TREATED EXPLANT
SN50-TREATED EXPLANT
SN50-TREATED EXPLANT
SN50-TREATED EXPLANT
SN50-TREATED EXPLANT
SN50-TREATED EXPLANT
SN50-TREATED EXPLANT
SN50-TREATED EXPLANT
SN50-TREATED EXPLANT
SN50-TREATED EXPLANT
SN50-TREATED EXPLANT
SN50-TREATED GLAND
SN50-TREATED PHENOTYPE
SN50-TREATED SECTION
STAT1
STAT3 PATHWAY
SELECTIVE BINDING
ANTI-SSDNA SELECTIVE BINDING
MONOCLONAL ANTIBODY F7-26 ANTI-SSDNA SELECTIVE BINDING
SER15
SIGMA
SIGMA
SIGNALING TECHNOLOGY
SIGNALING TECHNOLOGY
SIGNALING TECHNOLOGY
SMAD1
SMAD1
SMAD7
SMAD7
SMAD7
SMAD7
SMAD7
SMAD7 EXPRESSION
SMAD7 PROMOTOR ACTIVITY
SMAD7 SIGNALING
SNSG MOUSE
STATISTICAL ANALYSIS
STATISTICAL COMPARISON
STATISTICAL COMPARISON
STATISTICAL COMPARISON
STATISTICAL COMPARISON
TRANSFORMING GROWTH FACTOR BETA
TRANSFORMING GROWTH FACTOR BETA
TGF-Β EXPRESSION
TGF-Β FAMILY
TGF-Β FAMILY TRANSCRIPT
TGF-Β/ACTIVIN
TGF-Β1
TGF-Β2
TUMOR NECROSIS         FACTOR
TUMOR NECROSIS         FACTOR
TUMOR NECROSIS         FACTOR
TUMOR NECROSIS         FACTOR
TUMOR NECROSIS         FACTOR
TUMOR NECROSIS         FACTOR
TUMOR NECROSIS         FACTOR
TUMOR NECROSIS         FACTOR
TUMOR NECROSIS         FACTOR
TNF SUPPLEMENTATION
TNF SUPPLEMENTATION
TNF SUPPLEMENTATION
TNF SUPPLEMENTATION
TNF SUPPLEMENTATION
INDUCED NF-ΚB TNF SUPPLEMENTATION
TNF-MEDIATED RECOVERY
TNFR1 SIGNAL
TNFR1 SIGNALING
TRAIL RECEPTOR
THR202
TOTAL SIGNAL INTENSITY
TRANSCRIPTOMIC ANALYSIS
TROWELL METHOD
TYR204
U/ML
U/ML
U/ML RTNF
U/ML RTNF
UTILIZING PROPRIETARY SOFTWARE
ZYMED MOUSE PCNA KIT
ABILITY
ABSENCE
ABSENCE
ABSENCE
ABSENCE
ABSENCE
ABSENCE
ABSENCE
ABSENCE
SN50 PEPTIDE ABSENCE
PRIMARY ANTIBODY ABSENCE
PRIMARY ANTIBODY ABSENCE
ABUNDANCE
ACCURACY
ACTIVATED CASPASE
ACTIVATED ERK1
ACTIVATED ERK2
ACTIVATED NF-ΚB
ACTIVATED P53-POSITIVE CELL
ACTIVATION
ACTIVATION
ACTIVATION
ACTIVATION
ACTIVATION
ACTIVATION
ACTIVATION
ACTIVATION
C-RAF ACTIVATION
CASPASE EFFECTOR ACTIVATION
PROAPOPTOTIC ACTIVATION
ERK1 ACTIVATION
TUMOR NECROSIS         FACTOR ACTIVATION
ADDITION
ADDITION
ALGORITHM
ALTERED EXPRESSION
ALTERED EXPRESSION
ANALYZED SN50-TREATED
ANALYZED CONTROL
ANALYZING YEAST PROTEIN
ANTI-NF-ΚB P65 ANTIBODY EXPERIMENT
ANTI-PCNA
ANTI-APOPTOTIC FUNCTION
C-RAF ANTI-APOPTOTIC FUNCTION
ANTI-CLEAVED CASPASE
ANTI-CLEAVED PARP
ANTI-PHOSPHORYLATED ERK1
ANTI-PHOSPHORYLATED C-RAF(SER259) ANTIBODY
ANTI-SSDNA
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY
ANTIBODY COMBINATION
APOPTOSI
APOPTOSI
APOPTOSI
APOPTOSI
APOPTOSI
APOPTOSI
APOPTOSI
APOPTOSI
APOPTOSI
APOPTOSI
APOPTOSI
APOPTOSI
APOPTOSI
APOPTOSIS PROTEIN
APOPTOSIS PROTEIN
APOPTOSIS TRANSCRIPT
APOPTOSIS TRANSCRIPT
APOPTOTIC CELL
APOPTOTIC CELL
APOPTOTIC INDEX
APOPTOTIC NUCLEUS
APOPTOTIC NUCLEUS
APOPTOTIC PATHWAY
APOPTOTIC PROTEIN
APOPTOTIC SIGNALING
APOPTOTIC-POSITIVE EPITHELIAL CELL NUCLEI/TOTAL EPITHELIAL CELL NUCLEUS
BIOINFORMATIC APPROACH
BIOLOGICAL SIGNALING PATHWAY
BIOLOGICAL SIGNIFICANCE
BIOTIN-LABELED GOAT ANTI-MOUSE IGG
BRANCHING MORPHOGENESI
C-RAF
C-RAF
C-RAF
C-RAF
C-RAF FUNCTION
C-RAF LEVEL
C-REL P75
CDNA EXPRESSION ARRAY ANALYSIS
CDNA EXPRESSION ARRAY
CDNA ARRAY
CDNA EXPRESSION
CDNA EXPRESSION ARRAY
CDNA EXPRESSION ARRAY ANALYSIS CDNA EXPRESSION ARRAY
CDNA PROBE
CDNA PROBE
CARRIER
CASPASE EFFECTOR
CASPASE GENE EXPRESSION
CASPASE3
CASPAS
CELL CYCLE
CELL CYCLE
CELL CYCLE
CELL CYCLE
CELL CYCLE
CELL-SPECIFIC DIFFERENCE
CELLULAR PATHWAY
CERVICAL DISLOCATION
CHEMILUMINESCENCE
CLASSIC EPITHELIAL-MESENCHYMAL INTERACTION
DEVELOPMENTAL PROGRAM CLASSIC EPITHELIAL-MESENCHYMAL INTERACTION
CLONTECH
COLLECTIVE DYNAMIC
COM
COMPENSATORY ANTIAPOPTOTIC
COMPENSATORY ANTIAPOPTOTIC PATHWAY
CONCENTRATION
CONTAINING LYSINE-RICH HISTONE
CONTROL E15
CONTROL E15
CONTROL CDNA
CONTROL EXPLANT
CONTROL MEDIUM
CONTROL MEDIUM
CONTROL MEDIUM
CONTROL OLIGONUCLEOTIDE
CONTROL V.
COWORKER
COWORKER
CROSS-REACTIVE
CROSS-REACTIVE
CYCLIN D2
CYTOKINE IL-1Β
CYTOKINE
CYTOPLASM
CYTOPLASM
CYTOPLASM
CYTOPLASMIC DISTRIBUTION
CYTOPLASMIC DOMAIN
FAS RECEPTOR CYTOPLASMIC DOMAIN
DECLINING PCNA
DECREASED DNA STABILITY INDUCED
DECREASED GR
DECREASED CELL PROLIFERATION
DECREASED STABILITY
DNA DECREASED STABILITY
DEFINED CONDITION
DEMONSTRATION
DENSITOMETRIC ANALYSIS
DENSITOMETRY
DEVELOPMENTAL PROGRAM
DISCOVERED CORRELATION
DISCRIMINATING CONTROL
DISCRIMINATING CONTROL
DIVERSE PATHWAY
DIVERSE SIGNAL TRANSDUCTION PATHWAY
DOSE-DEPENDENT
DOWNREGULATED CASPASE
DYNAMICAL SYSTEM
DYSPLASTIC SMG PHENOTYPE
EMBRYONIC SMG
EMBRYONIC SMG CELL PROLIFERATION
EMBRYONIC SMG DEVELOPMENTAL HOMEOSTASI
EMBRYONIC SMG MORPHOGENESI
EMBRYONIC SMG MORPHOGENESI
EMBRYONIC SMG
EMBRYONIC MUCIN
EMERGING SMG PHENOTYPE
ENDOTHELIAL LE-II CELL
ENHANCED SIGNAL-PROPAGATION SPEED
EOSIN
EOSIN HISTOLOGY
EPITHELIAL CELL CYTOPLASM
EPITHELIAL CELL NUCLEUS
EXCLUSIVE
EXOGENOUS PEPTIDE
EXPANDED MODEL
EXPERIMENTAL GROUP
EXPERIMENTAL GROUP
EXPERIMENTAL GROUP
EXPERIMENTS TIME
EXPLANT SIZE
EXPLANT
EXPLANT
EXPLANT
EXPLANT
EXPLANT
EXPLANT
EXPLANT
EXPLANT
EXPLANT
EXPLANT
EXPLANT
EXPLANT
EXPLANTS CULTURED
EXPLANTS CULTURED
EXPLANTS CULTURED
EXTENSIVE APOPTOSI
EXTRACELLULAR COMPONENT
FIXATIVE
FIXED
FMOL/GLAND
FOLD-CHANGE
FOLD-CHANGE
FUNCTIONAL CATEGORY
FUNCTIONAL GROUP
FUNCTIONAL GROUP
FUNCTIONAL GROUP
FUNCTIONAL RELATIONSHIP
GENE EXPRESSION
GENE EXPRESSION
GENE EXPRESSION
GENE EXPRESSION
GENE EXPRESSION
GENE REGULATION
GENETIC NETWORK
GENETIC NETWORK
GENETIC NETWORK
GESTATION
GESTATION
GLUCOCORTICOID RECEPTOR
GLUCOCORTICOID RECEPTOR
GOAT-ANTI MOUSE IGG
GP130
GROWTH FACTOR PATHWAY TRANSCRIPT
GROWTH FACTOR PATHWAY
GROWTH FACTOR
GROWTH FACTOR
HEMATOXYLIN
HEMATOXYLIN
HEMATOXYLIN
HEMATOXYLIN
HISTOLOGICAL
HISTOLOGY
HOMOSCEDASTICITY
HR
HYBRIDIZATION SIGNAL
CONTROL OLIGONUCLEOTIDE HYBRIDIZATION SIGNAL
IMMUNOCHEMICAL ANALYSIS
IMMUNOCHEMISTRY
IMMUNODETECTABLE NF-ΚB
IMMUNOLOCALIZATION SMG
IMMUNOSTAINING
INACTIVE FORM
INACTIVE PROTEIN
INACTIVE PROTEIN
INCLUDING PARP CLEAVAGE
INCLUDING TRANSCRIPTION FACTOR
INCREASED CHK1
INCREASED ERK
INCREASED ERK1 ACTIVATION
INCREASED EXPRESSION
DIVERSE SIGNAL TRANSDUCTION PATHWAY INCREASED EXPRESSION
INCREASING BMP1
INDUCED NF-ΚB
INDUCING TRAF
INDUCTION
INDUCTION
NF-ΚB INDUCTION
APOPTOSI INDUCTION
INDUCTIVE EFFECT
INHIBITED NB-ΚB ACTIVATION
INHIBITED NF-ΚB
INHIBITED NF-ΚB
INHIBITORY PROTEIN IΚB
INTEGRAL
INTEGRATOR
INTENSIVE STAINING
NON-APOPTOTIC NUCLEUS INTENSIVE STAINING
INTERCONNECTION
INTERCONNECTION
INTERCONNECTION
INTERRUPTION
SMG DEVELOPMENT INTERRUPTION
INTRACELLULAR RECOGNITION MECHANISM
NUCLEAR LOCALIZATION           SEQUENCE INTRACELLULAR RECOGNITION MECHANISM
KEY PATHWAY
KEY ROLE
LAMIN
LOCALIZATION SEQUENCE
LUMEN FORMATION
LUMEN FORMATION
LUMEN-CONTAINING
MRNA
MRNA ABUNDANCE
MRNA ABUNDANCE
MRNA LEVEL
MRNA LEVEL
MRNA TRANSCRIPT LEVEL
MSN50-TREATED SMG
MSN50-TREATED EXPLANT
MSN50-TREATED EXPLANT
MSN50-TREATED EXPLANT
MEMBRANE FRAGMENTATION
MEMBRANE FRAGMENTATION
METAFANE
METHOXYFLURANE
MG ASCORBIC ACID/ML
MICROANATOMY
MOLECULAR PATTERN
MONOCLONAL ANTI-PHOSPHORYLATED P53
MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY F7-26
MOUSE TNF
MOUSE CDNA
MOUSE EMBRYO
MOUSE NEONATAL SUBMANDIBULAR SALIVARY GLAND
MOUSE P50
MOUSE P65
MULTIDIMENSIONAL RESPONSE
MULTIPROTEIN ASSAY
MURINE T CELL
MUTANT PEPTIDE
MUTANT PEPTIDE
MUTANT PEPTIDE-TREATED EXPLANT
NANOGRAM LEVEL
NEGATIVE CONTROL
NEGATIVE CONTROL
NEGATIVE CONTROL
NEGATIVE FEEDBACK
NEGATIVE REGULATION
NETWORK COMPONENT
NEURAL NETWORK
NODAL
NODAL
NON-APOPTOTIC NUCLEUS
NON-APOPTOTIC NUCLEUS
NONLINEAR DYNAMIC
NONLINEAR ORGANOGENESI
NONSPECIFIC EFFECT
EXOGENOUS PEPTIDE NONSPECIFIC EFFECT
NORMALIZATION
TRANSCRIPT ABUNDANCE NORMALIZATION
NUCLEUS
NUCLEUS
NUCLEUS
NUCLEUS
NUCLEUS
NUCLEUS
NUMEROUS COMPONENT
GENETIC NETWORK NUMEROUS COMPONENT
NYLON MEMBRANE WWW
OBSERVATION
OPTIMAL EXPERIMENTAL CONDITION
ORAL EPITHELIUM
ORGANOGENESI
OUTGROWTH
OUTPUT
P100
P105
P50
P53
P53
P53
P53
P53
P53
P53 PROTEIN
P53 TRANSACTIVATION
P53-DEPENDENT
P53-INDEPENDENT PATHWAY
P53-POSITIVE EPITHELIAL CELLS/TOTAL EPITHELIAL CELL
P57
P57
P65
P65
P65
P65 HETERODIMER
PAIR-WISE COMPARISON
PARAMETRIC STATISTICAL TESTING
PATHWAY ACTIVITY
PATHWAY COMPONENT
PEPTIDE
PEPTIDE
PEPTIDE SN50
PEPTIDE SN50
PEPTIDE SN50
PERIPHERAL BLOOD LYMPHOCYTE
PG/GLAND
PHENOMIC
PHENOTYPE
PHENOTYPE
SN50-TREATED SMG PHENOTYPE
PHENOTYPE
PHENOTYPIC OUTCOME
NODAL PHENOTYPIC OUTCOME
PHOSPHATE
PHOSPHO-P44
PHOSPHOR IMAGING
PHOSPHORIMAGING
PHYSIOLOGIC FUNCTION
PHYSIOLOGICALLY IMPORTANT
PLUG DAY
POINT PARAPLAST
POLYCLONAL GOAT ANTI-NF-ΚB P50 ANTIBODY
POLYCLONAL GOAT ANTI-NF-ΚB P65
POSITIVE CONTROL
POTENTIATES APOPTOSI
POTENTIATING APOPTOSI
PREIMMUNE RABBIT SERUM
PREIMMUNE SERUM
PREIMMUNE SERUM
PRESUMPTIVE ACINI
PREVENTING DNA DENATURATION
PREVENTING TRANSPORT
PRIMARY ANTIBODY
PRIMARY ANTIBODY
PRIMARY CELL
PRIMORDIA
PROAPOPTOTIC
PROAPOPTOTIC
PROAPOPTOTIC SIGNAL
PROBE PAIR
PROBE SET INTENSITY
PROTECTIVE EFFECT
PROTEIN
PROTEIN
PROTEIN
PROTEIN
PROTEIN DIFFERENCE
PROTEIN EXPRESSION
PROTEIN EXPRESSION
PROTEIN EXPRESSION
PROTEIN EXPRESSION
PROTEIN EXPRESSION
PROTEIN EXPRESSION
PROTEIN EXPRESSION
PROTEIN EXPRESSION
PROTEIN EXPRESSION CHANGE
PROTEIN LEVEL
PROTEIN-PROTEIN INTERACTION
PROTEIN-PROTEIN INTERACTION
PROTEINASE K
PROTEOMIC
PROTEOMIC ANALYSIS
PROTEOMIC STUDY
PSEUDOCOLORED IMAGE
RTNF
RTNF
RTNF CONCENTRATION
RAPID PHOSPHORYLATION
RECEPTOR COMPLEX
RECONSTITUTION
REGULATORY MECHANISM
CASPASE GENE EXPRESSION REGULATORY MECHANISM
RELATIONSHIP
RELATIVE CHANGE
RELATIVE IMPORTANCE
RELATIVE IMPORTANCE
RELATIVE IMPORTANCE
RELATIVE IMPORTANCE
RELATIVE IMPORTANCE
RELATIVE IMPORTANCE
RELATIVE IMPORTANCE
RELATIVE IMPORTANCE
RELATIVE IMPORTANCE
RELATIVE IMPORTANCE
RELATIVE LEVEL
RELATIVE LEVEL
REPLICATE CULTURE
ROUTINE HEMATOXYLIN
SALIVARY GLAND
SECONDARY EFFECT
NF-ΚB SIGNALING SECONDARY EFFECT
SEQUELLAE
APOPTOSI SEQUELLAE
SERUMLES
SIGNAL DYNAMIC
SIGNAL TRANSDUCTION
SIGNAL TRANSDUCTION
SIGNAL TRANSDUCTION
SIGNAL TRANSDUCTION
SIGNAL TRANSDUCTION
SIGNAL TRANSDUCTION PROTEIN
SIGNALING NETWORK
SIGNALING PATHWAY
SIGNALING PATHWAY
SIGNALING PROTEIN
SMALL-WORLD
SMALL-WORLD COUPLING
SOFTWARE PACKAGE
SPATIAL DISTRIBUTION
SPATIAL DISTRIBUTION
NF-ΚB SPATIAL DISTRIBUTION
NF-ΚB P65 SPATIAL DISTRIBUTION
SINGLE STRANDED DNA
SINGLE STRANDED DNA
STEADY-STATE MEASURE
SUPERIMPOSITION
SUPPLEMENTATION
SYNCHRONIZABILITY
T-TEST
TARGET GENE
TARGET GENE
THERMAL DENATURATION
TIME-BOUND
TOTAL ERK1 PROTEIN
TOTAL ERK2 PROTEIN
TOTAL RNA
TRAFFIC GRID
TRANSCIPTOMIC ANALYSIS
TRANSCRIPT ABUNDANCE
TRANSCRIPT CHANGE
TRANSCRIPTION
TRANSCRIPTION FACTOR
TRANSCRIPTION FACTOR
NFAT TRANSCRIPTION FACTOR
TRANSCRIPTIONAL CONTROL
TRANSCRIPTIONAL RESPONSE
TRANSCRIPTOMIC
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSREPRESS NF-ΚB
TRANSREPRESSES NF-ΚB
TREATMENT GROUP
UPREGULATION
VI
VISUALIZATION
ΚB RESPONSE ELEMENT
ΚB RESPONSE ELEMENT
ΜG/ML
ΜG/ML
ΜG/ML
ΜG/ML SN50
ΜG/ML SN50
ΜG/ML SN50 PEPTIDE
ΜG/ML MSN50
ΜG/ML MUTANT SN50
ΜG/ML MUTANT SN50
SN50 ΜG/ML
ΜM
SUBMANDIBULAR         SALIVARY GLAND
SMG
NUCLEAR LOCALIZATION           SEQUENCE
NLS
MUTANT SN50
MSN50
PROBABILISTIC           NEURAL NETWORK
PNN
GR
HUMAN SALIVARY GLAND
HSG
GR
PHOSPHATE BUFFERED SALINE
PBS
MUTANT SN50
MSN50
SINGLE-STRANDED DNA
SSDNA
WESTERN BLOT ANALYSIS
blot analyses
2-D WESTERN MULTIPROTEIN
MULTIPROTEIN
NF-ΚB TRANSLOCATION
SIGNAL TRANSDUCTION
RESEARCH
functions
CANALICULAR
CANALICULAR
CLONTECH
ATLAS IMAGE
CONNECTION
MAP
MAP
MAP
MAP
MAP
MAP
MAP
PROTEOME ANALYSIS
SYSTEM E15 SMG
E15 SMG
E15
D2
fragmentation
REPAIR
SMG PRIMORDIA
SMG
SMG PRIMORDIA
SMG
controls
PRIMORDIA
SMG
EPITHELIAL CELL
CELL APOPTOSIS
EPITHELIAL CELL
CELL PROLIFERATION
SOLUTION
receptors
PROTEIN EXPRESSION
PROTEIN EXPRESSION
GENE/PROTEIN
CORT/GR FUNCTION
CORT/GR
JUNKRAT
JURKAT
kinase
pathways
MAB
MAB
MAB
MAP
MAP
MAP
TRANSCRIPTS
MAP
TRANSCRIPTS
MAP
TRANSCRIPTS EXHIBIT
ACTIVATION
ACTIVATION
ACTIVATION
inhibition
inhibition
inhibition
inhibition
inhibition
P50
P50
P50
P50
P50
P52
P65
redistribution
NF-ΚB RESPONSE
signals
TRANSCRIPTION FACTOR
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
inhibition
NF-ΚB-INHIBITED
NF-ΚB-INHIBITED
TRANSCRIPTION
TRANSCRIPTION
transcripts
transcripts
CELL PROLIFERATION
CELL PROLIFERATION
PCNA-POSITIVE
analyses
analyses
analyses
analyses
analyses
PNN ANALYSIS
PNN ANALYSIS
PNN ANALYSIS
MEETING
NEURAL NETWORK
PROBABILISTIC NEURAL NETWORK
NEURAL NETWORK ANALYSIS
NETWORK ANALYSIS
TOTAL RNA
RELA
P68
GENES
NUCLEASE
NUCLEASE
CORT
CORT
GR
GR
GR
developments
developments
developments
DYSPLASIA
SMG EPITHELIA
EPITHELIA
EPITHELIAL CELL PROLIFERATION
CELL PROLIFERATION
PHENOTYPE
PHENOTYPE
SMG
PEPTIDE
PHENOTYPE
PHENOTYPE
PHENOTYPE
treatments
treatments
treatments
SN50-AND MSN50 PEPTIDE-TREATED
MSN50
PEPTIDE-TREATED
NF-ΚB INHIBITION
inhibition
inhibition
SN50-SUPPLEMENTED
SN50-TREATED
E15
SN50-TREATED
E15
SN50-TREATED
E15
SN50-TREATED
E15
SN50-TREATED
E15
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
SN50-TREATED
PHENOTYPE
SN50-TREATED
SMAD7
expressions
SMAD7
SMAD7
analyses
expressions
SUPPLEMENTATION
SUPPLEMENTATION
SUPPLEMENTATION
SUPPLEMENTATION
SUPPLEMENTATION
RECOVERY
signals
analyses
U/ML
U/ML
PROPRIETARY SOFTWARE
PCNA
CASPASE
ERK1
ERK2
ACTIVATED P53-POSITIVE
P53-POSITIVE
expressions
expressions
SN50-TREATED
controls
ANTI-NF-ΚB P65
ANTI-NF-ΚB
P65
functions
ANTI-CLEAVED
CASPASE
ANTI-CLEAVED
PARP
ERK1
TRANSCRIPTS
TRANSCRIPTS
pathways
epithelial
epithelial
significance
GOAT ANTI-MOUSE IGG
ANTI-MOUSE IGG
anti-mouse
functions
P75
CDNA EXPRESSION
CDNA
EXPRESSION ARRAY ANALYSIS
ARRAY ANALYSIS
CDNA EXPRESSION
expressions
CDNA EXPRESSION
GENE EXPRESSION
DISLOCATION
EPITHELIAL-MESENCHYMAL INTERACTION
antiapoptotic
LYSINE-RICH HISTONE
controls
E15
controls
E15
controls
controls
controls
controls
controls
controls
oligonucleotide
controls
cyclin
D2
distribution
domains
PCNA
DNA
GR
CELL PROLIFERATION
analyses
controls
controls
DIVERSE SIGNAL TRANSDUCTION
transduction
CASPASE
SMG PHENOTYPE
SMG
SMG
EMBRYONIC SMG
SMG CELL PROLIFERATION
CELL PROLIFERATION
SMG
SMG
EMBRYONIC SMG
SMG
EMBRYONIC SMG
SMG
mucin
SMG PHENOTYPE
SMG
ENDOTHELIAL LE-II
HISTOLOGY
EPITHELIAL CELL
CELL CYTOPLASM
EPITHELIAL CELL
PEPTIDE
times
APOPTOSIS
genes
expressions
genes
expressions
genes
expressions
genes
expressions
genes
expressions
genes
REGULATION
receptors
receptors
MOUSE IGG
GROWTH FACTOR PATHWAY
GROWTH FACTOR
growth
GROWTH FACTOR
growth
growth
growth
signals
PARP
including transcription
tfs
CHK1
ERK
ERK1 ACTIVATION
ERK1
expressions
BMP1
TRAF
effects
NB-ΚB ACTIVATION
PROTEIN IΚB
KEY
KEY
localization
FORMATION
FORMATION
MRNA TRANSCRIPT
MSN50-TREATED
SMG
MSN50-TREATED
MSN50-TREATED
MSN50-TREATED
fragmentation
fragmentation
ASCORBIC ACID/ML
ANTI-PHOSPHORYLATED P53
MONOCLONAL ANTIBODY
TNF
NEONATAL SUBMANDIBULAR SALIVARY GLAND
smg
SUBMANDIBULAR
P50
P65
responses
MURINE T
TS
PEPTIDE
PEPTIDE
MUTANT PEPTIDE-TREATED
PEPTIDE-TREATED
controls
REGULATION
effects
MEMBRANE WWW
epithelium
P53
P53
transactivation
P53-INDEPENDENT
epithelial
P65
heterodimer
STATISTICAL TESTING
pathways
pathways
SN50
SN50
SN50
PERIPHERAL BLOOD
functions
PARAPLAST
POLYCLONAL GOAT ANTI-NF-ΚB
ANTI-NF-ΚB
P50
POLYCLONAL GOAT ANTI-NF-ΚB
GOAT ANTI-NF-ΚB P65
ANTI-NF-ΚB P65
ANTI-NF-ΚB
controls
APOPTOSIS
POTENTIATING
APOPTOSIS
ACINI
DNA DENATURATION
DNA
TRANSPORT
signals
probes
probes
effects
expressions
expressions
expressions
expressions
expressions
expressions
expressions
expressions
PROTEIN EXPRESSION
KS
analyses
CONCENTRATION
phosphorylation
receptors
HEMATOXYLIN
signals
signals
transduction
signals
transduction
signals
transduction
signals
transduction
signals
transduction
SIGNAL TRANSDUCTION
signals
transduction
pathways
packages
distribution
distribution
targets
GENES
targets
GENES
denaturation
ERK1
ERK2
RNA
TRAFFIC
analyses
transcripts
transcripts
TRANSCRIPTION
TRANSCRIPTION
controls
treatments
ΚB RESPONSE
ΚB RESPONSE
ΜG/ML
SN50
ΜG/ML
SN50
ΜG/ML SN50
ΜG/ML
SN50 PEPTIDE
SN50
ΜG/ML
MSN50
ΜG/ML
MUTANT SN50
mutant
ΜG/ML
MUTANT SN50
mutant
